Abstract
Epitope variability is one of the greatest obstacles to development of synthetic peptide vaccines. Based on a recently described hypervariable epitope (aa 414-434) on the envelope glycoprotein (gp130) to simian immunodeficiency virus (SIV mac 142), we have developed a novel approach to account for epitope variability. We have prepared, in a single synthesis, a cocktail of peptides, designated a hypervariable epitope construct (HEC), which collectively represent all the in vivo variability seen in an epitope. The HEC represents permutations of amino acid substitutions found in the epitope and has been able to induce antibodies with enhanced binding to native SIV and broad immunoreactivity to related epitope analogues.
Original language | English (US) |
---|---|
Pages (from-to) | 736-740 |
Number of pages | 5 |
Journal | Vaccine |
Volume | 12 |
Issue number | 8 |
DOIs | |
State | Published - 1994 |
Keywords
- epitope variability
- Hypervariable epitope constructs
- simian immunodeficiency virus
ASJC Scopus subject areas
- Immunology
- Microbiology
- Virology
- Infectious Diseases
- Public Health, Environmental and Occupational Health
- veterinary(all)